[Pulmonary zygomycosis in a patient treated for invasive aspergillosis].
We report a pulmonary mucormycosis due to Absidia corymbifera. It occurred in a leukemic patient treated for a probable aspergillosis regressing after voriconazole treatment. The patient responded to surgery and a combination of liposomal amphotericin B and itraconazole. He was alive and well after 7-months of follow up.
Tricot
S
S
Service des maladies du sang, hôpital Huriez, CHRU, 59037 Lille, France.
Gastine
T
T
Sendid
B
B
Wurtz
A
A
de Botton
S
S
Alfandari
S
S
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications*; D004359:Drug Therapy, Combination; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications; D008297:Male; D013902:Radiography, Thoracic; D012141:Respiratory Tract Infections / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D016896:Treatment Outcome; D020096:Zygomycosis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B